Sclerostin Inhibition in the Management of Osteoporosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Link
http://link.springer.com/content/pdf/10.1007/s00223-016-0126-6.pdf
Reference66 articles.
1. Tsai JN, Uihlein AV, Lee H, Kumbhani R, Siwila-Sackman E et al (2013) Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. Lancet 382:50–56
2. Tsai JN, Uihlein AV, Burnett-Bowie S-AM, Neer RM, Zhuy Y, Derrico N, Lee H, Bouxsein ML, Leder BZ (2015) Comparative effects of teriparatide, denosumab and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT study. J Bone Miner Res 30:39–45
3. Baron R, Kneissel M (2013) Wnt signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19:179–192
4. Ke HZ, Richards WG, Li X, Ominsky MS (2012) Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev 33:747–783
5. Weivoda MM, Oursler MJ (2014) Developments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions. Curr Osteoporos Rep 12:107–114
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Effects of Switch Therapy in Osteoporosis Treatment after Romosozumab after Comparing with Prior Treatment;Journal of Osteoporosis;2024-01-09
2. Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults;npj Aging;2023-09-04
3. The role of sclerostin in lipid and glucose metabolism disorders;Biochemical Pharmacology;2023-09
4. Targeting SOST using a small-molecule compound retards breast cancer bone metastasis;Molecular Cancer;2022-12-29
5. Romosozumab for the treatment of postmenopausal women at high risk of fracture;Expert Opinion on Biological Therapy;2022-12-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3